5-year Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay Results

Stopped Study endpoints completed with lower than anticipated enrollment. Last patient enrolled completed final visit February 2021.

Conditions

• Cutaneous Melanoma

Sponsor

Castle Biosciences Incorporated